BRKR · Bruker Corp
Price
Snapshot
50 fields · last close| Market Cap | $9.35B |
| P/E | — |
| Float | 111.2M |
| Beta | 1.25 |
| Volatility | 31.2% |
| Exchange | NASDAQ |
| Sector | Life Sciences Tools & Services |
| Cap tier | Mid cap |
| Macro sensitivity | High |
| Clavix score | 57 |
| Price | 62.22 |
| Change | +1.35% |
| Prev Close | 61.39 |
| Open | 63.37 |
| Day Low | 60.40 |
| Day High | 63.49 |
| Avg Vol | 3 |
| Avg $ Vol | $154.1M |
| 52W High | 65.30 |
| 52W Low | 30.09 |
| 52W Pos | 91.3% |
| From High | −4.72% |
| From Low | +106.78% |
| Max DD 1Y | −39.85% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +8.11% |
| SMA 50 | +6.91% |
| SMA 200 | +28.31% |
| RSI (14) | 57.7 |
| Vol 30D | 54.7% |
| Vol 90D | 69.8% |
| 1Y Range | 30–65 |
| Daily bars | 516 |
| Perf Week | +14.90% |
| Perf Month | +4.67% |
| Perf Quarter | +7.27% |
| Perf Half Y | +82.55% |
| Perf Year | +91.19% |
| Perf YTD | +29.33% |
| Prev Day | +1.35% |
| Clavix | C |
| Debt / Eq | 0.76 |
| Curr Ratio | 1.73 |
| Int Cover | 1.8× |
| FCF Margin | 6.3% |
| Rev Growth | +5.2% |
| Profit | Unprofitable |
| Leverage | Moderate |
| Sector rank | 17 / 19 |
Clavix risk grade
regraded every trading dayBRKR grades C, 57 of 100. Steadiest on News Sentiment (68), most exposed on Price Stability (39, fragile). 2 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 17 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| BRKR | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.25 | 1.18 |
| Volatilityannualized | 31.2% | 29.6% |
| Max drawdown, past yearworst peak-to-trough fall | −39.8% | — |
| Typical daily movemedian absolute daily change | 1.92% | — |
| Days beyond ±3%of the last 252 sessions | 8333% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| BRKR | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.25 | 1.18 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| BRKR | |
|---|---|
| 1 week | +14.9% |
| 1 month | +4.7% |
| Year to date | +29.3% |
| 1 year | +91.2% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| BRKR | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 27 Jul |
| Average score0 most bearish, 100 most bullish | 58 |
| Bullish · bearisharticles above 60 · below 40 | 19 · 5 |
| Directionarticles whose tone is improving vs worsening | 19 ↑ 5 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| BRKR | |
|---|---|
| Revenue growthyear over year | +5.2% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openBruker announced it received a multi-system order from UC Berkeley for high-field Nuclear Magnetic Resonance (NMR) instruments, including 800 MHz-class systems, to upgrade the research infrastructure at the university's Pines Magnetic Resonance Center.
Bruker Corporation declared a $0.05 per share quarterly dividend, payable October 7th to those holding shares by the September 21st record date. The annualized dividend yield is 0.3%.
Wellington Management Group disclosed in a routine quarterly SEC filing that it bought a new position in Bruker Corporation during the second quarter, purchasing 22,683 shares worth about $1.36 million.
VELA Investment Management LLC cut its holdings in Bruker Corporation (BRKR) by 23.0% during the second quarter, selling 22,370 shares and leaving it with 74,924 shares, according to the fund's SEC disclosure.
Bruker's energy and supercon technologies unit (BEST) signed a supply deal with Luvata to scale up production of RRP superconductor wires, specialized wires that carry extremely high electrical currents inside powerful magnets, for magnetic confinement fusion (a method of containing plasma for fusion using magnets). The article also notes BEST's Q2 revenue rose 11.9% year over year to $74.2 million, with first-half revenue up 12.3% to $141 million.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| QGEN | Qiagen NV | B+ | $8.93B | 21.82 | 0.60 | Compare |
| TXG | 10X Genomics Inc | C- | $9.98B | — | 2.04 | Compare |
| RGEN | Repligen Corp | B- | $9.98B | 240.33 | 1.14 | Compare |
| AVTR | Avantor Inc | B- | $10.50B | — | 0.97 | Compare |
| TECH | Bio-Techne Corp | B | $11.35B | 62.40 | 1.30 | Compare |
| CRL | Charles River Laboratories International Inc | B- | $13.27B | — | 1.41 | Compare |
| TEM | Tempus AI Inc | D- | $14.05B | — | 2.33 | Compare |
| RVTY | Revvity Inc | B | $16.01B | 67.38 | 1.09 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.